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Introduction: Epidemiological studies that investigate alterations in the gut microbial composition 
associated with smoking are lacking. This study examined the composition of the gut microbiome in 
smokers compared with non-smokers. 
Methods: Stool samples were collected in a cross-sectional study of 249 participants selected from 
the Health Effects of Arsenic Longitudinal Study (HEALS) in Bangladesh.  Microbial DNA was 
extracted from the fecal samples and sequenced by 16S rRNA gene sequencing. The associations of 
smoking status and intensity of smoking with the relative abundance or the absence and presence of 
individual bacterial taxon from phylum to genus levels were examined. 
Results: The relative abundance of bacterial taxa along the Erysipelotrichi-to-Catenibacterium 
lineage was significantly higher in current smokers compared to never smokers.  The odds ratio 
comparing the mean relative abundance in current smokers with that in never smokers was 1.91 
(95% confidence interval [CI] = 1.36 to 2.69) for the genus Catenibacterium and 1.89 (95% CI = 1.39 
to 2.56) for the family Erysipelotrichaceae, the order Erysipelotrichale, and the class Erysipelotrichi 
((FDR-adjusted p-values = 0.0008 to 0.01).  A dose-response association was observed for each of 
these bacterial taxa.  The presence of Alphaproteobacteria was significantly greater comparing 
current with never smokers (OR = 4.85, FDR-adjusted p-values = 0.04).   
Conclusions:  Our data in a Bangladeshi population are consistent with evidence of an association 
between smoking status and dosage with change in the gut bacterial composition.   
Implications: This study for the first time examined the relationship between smoking and the gut 
microbiome composition. The data suggest that smoking status may play an important role in the 
composition of the gut microbiome, especially among individuals with higher levels of tobacco 
exposure.   























Despite the known and deadly risks of cigarette smoking 1, the prevalence of tobacco smoking has 
continued to rise in developing countries such as Bangladesh and other South Asian countries 2. 
Tobacco use is a risk factor for 6 of the 8 leading causes of death in the world, according to the 
World Health Organization 3.  The majority of the world’s current smokers now live in low to middle-
income countries, with South Asia being one of the largest areas on the globe for tobacco 
production and consumption 4, making the Bangladeshi population of interest to study the effects of 
tobacco use.  
 
The microbiota has emerged as having a potential role in smoking-related pathogenesis. The gut 
microbiota is composed of 1013 to 1014 microorganisms involved in physiological function such as 
digestion and metabolism, of which the majority are bacteria colonized from birth 5.  Modifications 
of the gut microbiota have been associated with chronic conditions such as obesity and 
inflammatory bowel disease 6. Even with a neutralized diet, the intestinal microbial composition of 
smokers and non-smokers is different 7.  Several studies in humans have reported that smoking is 
related to differences in the microbiome measured in saliva 8, sputum 9, subgingival 10, upper GI 11, 
throat 12, middle meatus 13 and bronchial wash 14 samples.  Mouse and rat models in the gut 
microbiota have shown significant changes in response to nicotine and smoke exposure 15.  Although 
a few studies have investigated whether the gut microbiome differs by smoking status 16-18, these 
studies included mostly Crohn’s disease patients or had a small sample size. Epidemiological studies 
























In this study, we examined the relationship between cigarette/bidi smoking and the gut microbiome 
in 250 participants, recruited from a large prospective cohort study, who provided fecal samples for 




Data was collected for this study as part of the Health Effects of Arsenic Longitudinal Study (HEALS), 
which is an ongoing, prospective cohort study located in Araihazar, Bangladesh. Details of the study 
were previously published and will be summarize briefly here 19.  Between October 2000 and May 
2002, an original cohort consisting of 11,746 married adults (to reduce loss to follow-up) between 
the ages of 18-75 years old were recruited from a well-defined 25 km2 geographical area. An 
expansion cohort of an additional 8,287 participants was recruited between 2006 and 2008. Trained 
physicians performed in-person visits biennially to collect demographic and lifestyle data using a 
standardized questionnaire 19.  The overall participation rate, estimated by the proportion of 
subjects who agreed to participate among the potential participants invited to the study, was 97%.  
Cohort participants received medical treatment at a field clinic that was set up for this purpose and 
to assist in follow-up and ancillary studies.  The Ethical Committee of the Bangladesh Medical 
Research Council and the Institutional Review Boards of Columbia University and the University of 
Chicago approved all study procedures.  Informed consent was obtained from all of the study 
participants. 
 
The study presented here was conducted to assess the relationship between smoking and the gut 






















the six villages surrounding the clinic to obtain fecal sample collection.  Four hundred participants 
between the ages of 25 and 50 years old free from any major illness were randomly selected.  The 
distribution of demographics or lifestyle variables was not significantly different from the overall 
HEALS participants (data not shown).  A total of 328 of the 400 fulfilled the eligibility requirements 
including absence of antibiotic use in the previous month and willingness to come to the clinic to 
provide stool samples and complete lifestyle questionnaires.  Of the 328 eligible participants, 300 
were recruited and 250 of these participants provided fecal samples. 
 
Fecal Specimen Collection 
Stool from a single bowel movement was collected in an empty ThermoFisher Scientific vial 
(Waltham, MA, USA) given to participants by a senior research officer at the field clinic for fecal 
sample collection.  Immediately stored in a -20°C freezer, samples were kept frozen until processing 
at the field laboratory for DNA extraction. 
 
Assessment of Tobacco Smoking Variables 
Detailed information on status of smoking was collected around the time of stool sample collection 
(never, former, and current).  Information on number of sticks per day was asked together regarding 
smoking cigarettes and bidis. Bidis are filterless locally produced thin cigarettes filled with tobacco 
and wrapped in leaves. Cigarettes and bidis are often sold individually in Bangladesh, however to 
facilitate comparison with other studies, we calculated packs per day as the number of sticks 
smoked per day divided by 20. Time since quitting smoking was calculated as the difference between 
the age at smoking cessation and the age at the time of the study visit. Current smokers of cigarettes 
and bidis were categorized as current smokers and past smokers of any tobacco products were 























DNA Extraction and 16S rRNA Gene Sequencing 
Total DNA was extracted from fecal samples at the field laboratory using the MOBIO PowerSoil DNA 
Isolation Kit (MO BIO Laboratories, Carlsbad, CA).  The 16S rRNA gene was amplified targeting the 
hypervariable V3-V4 region using universal primer set 347F 5′-GGAGGCAGCAGTRRGGAAT and 803R 
5′-GACTACHVGGGTATCTAATCC.  Agencourt AMPure XP (Beckman Coulter Life Sciences, IN) was used 
to purify PCR products and Agilent 4200 TapeStation (Agilent Technologies, CA) was used to quantify 
PCR products.   Performed polymerase chain reaction (PCR) amplification and sequencing methods 
are described in further detail previously 20. The Illumina MiSeq 300-cycles (2x300bp) reagent kit 
(Illumina, Inc., San Diego, CA) was used to pool and sequence Amplicon libraries at equimolar 
concentrations. One sample was not sequenced further and was excluded for failing PCR 
amplification. 
 
Bioinformatics and Quality Control  
QIIME (Quantitative Insights into Microbial Ecology) 1.8.0 21 was used to process sequencing data. 
Once demultiplexed, sequencing reads with low quality scores of <25 were removed. ChimeraSlayer 
22 was used to take out chimeric sequences. 
Pre-processed sequences were clustered into operational taxonomic units (OTUs) at 97% identity 
using UCLUST 23 against the Greengenes database 13.8 with the most abundant sequence in each 
OTU selected as a representative.  Greengenes database 13.8 and Ribosomal Database Project (RDP) 
Classifier 2.2 24 was used to assign taxonomy for each OTU from phylum to genus levels. QIIME was 
used to estimate several alpha diversity measures at the OTU level based on rarefied sequence 
count (10,000 sequences per sample). By calculating the number of observed OTUs and Chao1 






















abundance of microbes), was examined 25. The Shannon diversity index was used to assess evenness, 
a measure of the relative number of different taxa in each sample (or the distribution of the 
different microbes), 26.  
 
Statistical Analyses 
Descriptive analysis was conducted to compare demographic, lifestyle, and alpha diversity measures 
by smoking status using chi-square tests for categorical variables and t-tests for continuous 
variables. 
The number of reads for each taxon was divided by the total number of reads from all taxa within 
each individual sample to calculate relative abundance at the levels of phylum, class, order, family, 
and genus. 
The association between smoking status and beta diversity of the gut microbiome measured by 
unweighted Unifrac distance 27, weighted Unifrac distance 28 and Bray-Curtis distances matrices 29 
was evaluated using the microbiome regression-based kernel association test MiRKAT 30 adjusting 
for sex, age, BMI, betel quid use and education. The omnibus test (optimum MiRKAT) which 
simultaneously considers the above listed distances matrices  was conducted to report the overall 
result, since each individual distance matrix measurement just captures a specific association 
pattern. 
 
To evaluate the association between smoking status and the relative abundance of gut bacterial 
taxa, we used beta regression adjusting for sex, age, BMI, betel quid use and education, using the R 
package ‘betareg’ 31.  Beta regression was considered because this model is useful in microbiome 
studies where the continuous non-zero mean relative microbial abundance is the variable of interest 






















because the logarithm of zero is undefined.  The regression coefficient in the beta regression is the 
log odds of the mean relative abundance of the specific taxa in smokers compared to non-smokers.  
The exponent of the coefficient is the odds ratio of mean relative abundance comparing the two 
groups. We also used logistic regression models to assess the association between smoking status 
and the presence/absence of the gut bacterial taxa, adjusting for sex, age, BMI, betel quid use and 
education. To test this association, the abundance was re-coded as 1 if it was greater than 0, i.e., the 
taxon was present in the sample. Logistic regression model adjusting for sex, age, BMI, betel quid 
use and education was then used to fit the data. Only taxa with a prevalence of >10% and <90% 
were evaluated. The Benjamini-Hochberg procedure was performed for all p-values at each 
taxonomic rank to control the false discovery rate 33.  For bacterial taxa that were nominally 
significantly associated with smoking status, for either relative abundance or presence/ absence, we 
further assessed their association with packs of cigarettes smoked.  Because smoking was more 
prevalent in men (76.5%) than in women (13.5%), sensitivity analyses were also conducted in men 
only.  However, the results were similar and therefore sex-specific results were not presented to 
preserve the power of the analyses. Bacterial taxa that were differentially abundant in current 
smokers, former smokers, and with smoking dosage, as compared with never smokers, at either 
nominal or FDR-adjusted level, were plotted on a taxonomic tree (cladogram) using GraPhlAn 34. 
Since the study was originally designed to collect arsenic data, we performed a sensitivity analysis 
adding arsenic levels as an additional potential confounder in the beta regression model for the taxa 
that were significant in current compared to never smokers. 
RESULTS 
Sequencing Results 
From the 249 samples, approximately 8.6 million quality-filtered sequencing reads were obtained 
with an average of 34,520 reads per sample that were clustered into 108,987 OTUs.  There was a 






















classified into 19 phyla, 39 classes, 78 orders, 142 families, and 273 genera. Taxa with a relative 
abundance of less than 0.01% or without a name at each taxonomic level were removed, which left 
a total of 8 phyla, 16 classes, 24 orders, 40 families, and 54 genera in the final analyses. 
 
Characteristics of the Study Participants 
Characteristics of the study population are shown in Table 1.  Mean age of the study participants 
was 48.6 ± 7.9 (mean ± SD).  Average BMI for this lean population was 21.5 ± 4.1 kg/m2. Participants 
had an average of 2.4 years of formal education. Twenty-five percent of study participants were 
current smokers (n=62) and 14% were former smokers (n=36), while 61% never smoked (n=151). An 
average of 0.50 ± .31 packs of cigarettes/bidis per day were smoked by current smokers. Former 
smokers similarly consumed 0.47 ± 0.49 packs per day.  Current and former smokers were 
predominantly male (88.7% and 63.9% respectively), slightly older and leaner than those who never 
smoked and were more likely to have ever used betel quid. Current smokers were less educated 
compared to never smokers.  Blood pressure was not associated with smoking status, nor were 
alpha diversity measurements. 
 
Alpha diversity measurements compared by smoking status also did not exhibit significant 
differences (Table 1).  The association between smoking status and microbiome beta diversity 
measured by Unifrac distance, weighted Unifrac distance and Bray-Curtis was not significant (Table 
2).   
 
Associations of Smoking with Microbial Composition 
The relative abundances of 14 taxa were nominally significantly associated with smoking status 






















Erysipelotrichi-to-Catenibacterium lineage were significantly enriched among current smokers 
compared with never smokers after correction for multiple comparisons. The odds ratios comparing 
the mean relative abundance in current smokers with that in never smokers was 1.91 for genus 
Catenibacterium (FDR-adjusted p = 0.01), 1.89 for the family Erysipelotrichaceae (FDR-adjusted p = 
0.002), 1.89 for order Erysipelotrichales (FDR-adjusted p = 0.001), and 1.89 for class Erysipelotrich 
(FDR-adjusted p = 0.0008). Bacterial taxa along the Coriobacteriia-to-Collinsella lineage were also 
enriched among current smokers in comparison to never smokers; however, the FDR-adjusted p-
values were not significant.  
 
The presence/absence of five taxa were nominally significant in current smokers compared to never 
smokers (Table 4), with the class Alphaproteobacteria remaining significant after multiple 
comparisons correction (FDR-adjusted p=0.04).  Current smokers were 4.85 times more likely to 
have this class present in their microbiome than never smokers. 
 
For bacterial taxa that were nominally significantly associated with smoking status for either relative 
abundance or presence/ absence, we further assessed their association with packs of cigarettes 
smoked.  All of these four taxa in the Erysipelotrichi-to-Catenibacterium lineage exhibited a dose-
response relationship (FDR-adjusted p =0.01 for Catenibacterium, FDR-adjusted p=0.004 for 
Erysipelotrichi) with increasing mean relative abundance as packs per day of cigarettes/bidis 
increased (Table 5).  An increase in one pack per day was associated with an odds ratio of 1.88-1.90 
for mean relative abundance for these specific taxa. The family Peptostreptococcaceae, the genera 
Slackia, and Collinsella also had increasing mean relative abundance with increasing smoking dosage 
with odds ratios of 1.67, 2.75 and 1.73 associated with an increase of 1 pack per day (FDR-adjusted 






















related to increased smoking dosage and were 28.5 and 20.7 more likely to be present with an 
increase of 1 pack per day respectively (FDR-adjusted p=0.001, 0.048) (Table 5). 
 
In former smokers compared to never smokers, the relative abundances of 4 taxa, including 3 that 
remained significant after adjusting the p-values for multiple comparisons testing in current smokers 
(the family Erysipelotrichaceae, order Erysipelotrichales, and class Erysipelotrichi) were nominally 
associated with smoking status (Supplemental Table 1). A total of 12 taxa had higher prevalence 
among former smokers relative to never smokers at the nominal level (Supplemental Table 2), 
although none of the associations remained significant after correcting for multiple comparisons. 
For the four taxa that were significantly associated with current smoking (class Erysipelotrichi, order 
Erysipelotrichale, family Erysipelotrichaceae, and genus Catenibacterium) after adjusting for multiple 
comparisons (three of which were nominally significant in the former smokers), there was also a 
dose-response relationship between their relative abundance and the intensity of smoking.  
However, there was no correlation between the time since quitting and the relative abundance of 
these four taxa using linear regression adjusting for sex, age, BMI, education and betel quid use.  
However, our sample size was limited for this analysis.  Future studies with a larger sample size are 
needed to confirm the findings. 
Figure 1 shows an association map of the taxa that were significantly related to smoking status and 
smoking dosage (packs per day). The nodes on the tree first branch into each phylum, which are 
shown by differently colored sections, then class, order, family and genera.  The red highlighted taxa 
are those whose abundance was associated with smoking.  The orange highlighted taxa represent 
those for which their presence/absence was associated with smoking. The taxa for which both 
























There were no significant differences in arsenic levels between the current smokers, former 
smokers and control group. Adding arsenic as an additional potential confounder into the beta 
regression model for the relative abundance of the 4 taxa along the Catenibacterium-to- 
Erysipelotrichi lineage that were significantly different between current and never smokers, 
after adjusting for multiple comparisons, did not change the results.  In this model, the odds 
ratio comparing the mean relative abundance in current smokers with that in never smokers 
was 1.89 (95% confidence interval [CI] = 1.34 to 2.66) for the genus Catenibacterium (p-
value = 0.0002) and 1.89 (95% CI = 1.39 to 2.56) for the family Erysipelotrichaceae, the 
order Erysipelotrichale, and the class Erysipelotrichi (p-values < 0.0001).  
DISCUSSION 
In a Bangladeshi population, we found that the relative abundance of bacterial taxa along the 
Erysipelotrichi-to-Catenibacterium lineage, including the genus Catenibacterium, the family 
Erysipelotrichaceae, order Erysipelotrichales, and class Erysipelotrich were significantly higher in 
current smokers compared to never smokers, with each taxon exhibiting a dose-response 
relationship with packs of cigarettes smoked per day.  The class Alphaproteobacteria was 
significantly more prevalent in current compared to never smokers (FDR adjusted p = 0.04).   Genus 
Slackia, genus Collinsella, and other bacterial taxa along the same linages, including family 
Coriobacteriaceae, order Coriobacteriales, and class Coriobacteriia were also enriched among 
current smokers in comparison to never smokers; however, the FDR-adjusted p-values were not 























Data from this study suggests effect of cigarette smoking on the relative abundance of certain 
bacterial taxa in the gut remained even after smoking cessation. Of all the bacterial taxa in the 
gut that had significantly higher levels or had a significantly higher proportion of presence at 
the nominal level in current smokers compared with never smokers, the levels or presence of 
five bacterial taxa were also nominally significantly higher in former smokers, compared 
with never smokers.  These taxa included class Alphaproteobacteria, class Erysipelotrichi, 
order Erysipelotrichale, family Erysipelotrichaceae, and genus Slackia (comparing results in 
Table 3 vs. Supplemental Table 1, in Table 4 vs. Supplemental Table 2).  The association 
comparing former smokers and never smokers was weaker than that comparing current 
smokers and never smokers, suggesting that the effect, although lasting after quitting 
smoking, may diminish overtime.  All other taxa that were nominally significant in the 
current vs never smokers are not seen in former smokers.  
Several explanations have been proposed for the dysbiosis created by smoking, the simplest 
being cigarette exposure directly causes specific bacteria to enter the gut 
35
. Other hypotheses 
include immunomodulation 
15,36
, oxidative stress 
36-38
 or molecular changes to the cellular 
tight junctions and mucin composition of the gut 
15,36
.  
Epidemiologic studies on the association between cigarette smoking and gut microbiome measured 
in stool samples is limited.  Several studies in humans have reported that smoking is related to 
differences in the microbiome measured in saliva 8, sputum 9, subgingival 10, upper GI, throat 12, 
middle meatus 13 and bronchial wash 11,14 samples.  Given variations in the gut microbiome between 
communities, it is difficult to directly compare across studies.  Nonetheless, we found some 
similarities to other studies. Gram-positive class Coriobacteriia was nominally significant in our study 
in current vs never smokers, and was identified as enriched in current smokers in the oral 
microbiome 8,39.  This class has been implicated in oral diseases such as periodontitis, halitosis, and 























Several studies have investigated cigarette smoking in relation to the gut microbiome in patients 
with Crohn’s disease.  One study showed a decrease in richness, genus and species diversity and 
reduced relative abundance of Collinsella, Enterohabdus and Gordonibacter 17. Our study found a 
significant increase in Collinsella among current smokers, in contrast to the findings from this study, 
however we also found a dose response with Collinsella rendering the increase likely to be 
associated with smoking.  Collinsella is well suited to colonize mucosal surfaces, metabolizes amino 
acids, and may directly interact with the host 6. Higher abundance of Collinsella has been related to 
type 2 diabetes 42,43 and symptomatic atherosclerosis 44.  A study evaluating the effect of smoking 
cessation showed a decrease in Bacteroidetes (Prevotella spp. and Bacteroides spp.) and the classes 
Alphaproteobacteria and Betaproteobacteria after smoking cessation 18 . Interestingly, we found that 
the class Alphaproteobacteria, a gram-negative class in the phylum Proteobacteria, was 4.85 times 
more prevalent in current smokers than those who never smoked in our study. Alphaproteobacteria 
has been directly detected in cigarette samples 35.   
 
Our finding of the higher abundance of the Erysipelotrichi-to-Catenibacterium lineage and the higher 
prevalence/abundance of the genus Slackia in current smokers are highly significant and novel. The 
genus Catenibacterium is a Gram-positive, nonspore-forming and anaerobic genus from the family 
Erysipelotrichidae, which produces short chain fatty acids as products of glucose 
fermentation.  Catenibacterium has been associated with higher fat intake in a study of fecal 
samples in Seoul & Jeju Island in S. Korea 45. The class Erysipelotrich was found to be increased in 
murine gut in high-fat diets 46 and related to systemic inflammation 47. The family 
Erysipelotrichaceae has been linked to dyslipidemic phenotypes and systemic inflammation 48.  The 
genus Slackia has been suggested to be involved in lipid and xenobiotic metabolism 49, pro-






















in bacterial upregulation to detoxify cigarette smoke. A metagenomics study found an increase in 
genes involved in xenobiotic metabolism in smokers 50. It is likely that an increase in tobacco 
exposure would lead to an increase in bacteria involved in the xenobiotic degradation of the toxins 
associated with smoking, and our study found a positive correlation between the genus Slackia and 
the amount of cigarettes/bidis smoked per day and also an increased likelihood for this genus to be 
present with increasing tobacco exposure (28.5 times more likely per 1 pack of cigarettes/bidis), 
which may explain the increase found in current smokers in our study. Given the many toxicants 
found in cigarette smoke, it is not surprising to find the higher prevalence and/or abundance of 
these inflammatory bacteria in smokers. However, whether their enrichment could contribute to 
smoking-related diseases warrants future studies.   
 
A strength of this study is that it is the first study of the gut microbiome in South Asians, and includes 
participants who are free from frequent use of medications, supplements and antibiotics that 
disrupt the microbiome since it was conducted in rural community lacking basic health care services. 
Further, our findings align with other studies of the effect of smoking on the bacterial microbiome in 
other areas of the body and provide evidence of a dose-response relationship solidifying the results 
that certain taxa are more abundant in smokers.  Limitations of the study include the cross-sectional 
design, instead of prospective, however it is not expected to be biased as participation in the study 
was not likely dependent on both the composition of the gut microbiome and smoking status. 
Longitudinal studies to evaluate the effect of smoking and smoking cessation on gut microbiome 
composition would be helpful to determine causality.  The smoking dosage was based on the 
number of packs smoked per day since cotinine was not measured as part of the study.  However, 
the questionnaire used to assess smoking dosage was standard and analyses using the data on all-
cause mortality, prostate cancer mortality and multiple myeloma mortality, amongst others,  






















resolution to the genus level, and this lack prevents direct functional profiling.  Metagenomic 
sequencing studies to evaluate the relationship of the gut microbiome and smoking are needed to 
better understand these mechanisms. 
 
Our data suggest evidence of an association between cigarette/bidi smoking and the relative 
abundance of the genus Catenibacterium, family Erysipelotrichaceae, order Erysipelotrichales, and 
class Erysipelotrichi, with a dose-response indicating increased smoking exposure leads to an 
increase in relative abundance, and to the presence of the class Alphaproteobacteria. These changes 
in microbiome composition in association with smoking may be involved in the pathogenesis of 
several diseases.  Further studies are required to investigate the underpinnings of bacterial dysbiosis 
related to smoking, the impact of smoking on the metagenomic content of the gut microbiome, and 
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Figure 1. The association mapping results of current smokers vs. never smokers, former smokers vs. 
never smokers, and smoking dosage (packs per day) on the taxonomic tree (generated using GraPhlAn 
34). The nodes on the tree from inner to outer circles are the phylum, class, order, family and genus rank. 
The corresponding annotations are written in the reverse order.  
Taxa whose abundance is associated with smoking status are highlighted in red; taxa whose 
presence/absence is associated with smoking status are highlighted in orange; taxa where both 
presence/absence and abundance is associated with smoking status are highlighted in blue. Small circles 

























Table 1. Distribution of population characteristics and alpha diversity metrics by smoking status 
 
Overall 
(n = 249) 





(n =  151) 
Former 
(n = 36) 
Current  
(n = 62) 
P†  
Current 
BMI, kg/m2   21.5 ± 4.1  22.5 ± 4.2 20.8 ± 3.4 19.6 ± 3.3     0.03 <0.001 
        Missing - 1 - -   
Male, % 41.0 15.9 63.9 88.7 < 0.001 < 0.001 
Female, % 59.0 84.1 36.1 11.3 < 0.001 < 0.001 
Age, years 48.6 ± 7.9  46.4 ± 7.5 54.5 ± 5.8 50.5 ± 7.8 < 0.01 < 0.01 
Education, years#  2.4 ± 3.3  2.7 ± 3.6 1.8 ± 3.0 1.8 ± 1.1  0.15 0.03 
Ever betel quid use, % 50.6 43.1 69.4 58.1 <0.01 0.046 
Packs per day 
0.19 ± 
0.34 0 0.47 ±  0.49 0.50 ± .31 <0.001 
<0.001 








 108.8 ± 
14.2  0.15 
0.15 



























Shannon diversity index 4.5 ± 0.5  4.5 ± 0.6 4.5 ± 0.5 4.5 ± 0.5 0.62 0.83 




0.04 0.92 ± 0.04 0.92 ± 0.04 0.72 
0.87 
 
Data are presented as mean ± standard deviation (SD). 






















† n = 248 (missing data for one person). 













Former vs. Never  0.6869 0.6586  0.7917 0.8480 
Current vs. Never  0.0941 0.5342 0.2413  0.2210 
Smoking dosage (pack)  0.2241 0.8524 0.6630 0.3630 
 
*The model has been adjusted for sex, age, BMI, betel quid use, and education. 













































*Odds Ratio of the mean relative abundance of taxa comparing current smokers to never smokers 
adjusting for age, sex, BMI, education, and betel quid use using beta regression with logit 
transformation based on continuous variable of relative abundance of taxa, replacing zeros with 10-6.  A 
total of 142 bacterial taxa were tested.  Only the ones with nominal significance were listed. 
†P values were corrected for multiple testing using the Benjamini-Hochberg procedure to control the 
false discovery rate (FDR) ≤ 5%. 
Taxonomy 






Class Erysipelotrichi 1.89 (1.39, 2.56) 0.0001 0.0008 
Class Coriobacteriia 1.46 (1.03, 2.06) 0.03 0.25 
Order Erysipelotrichales 1.89 (1.39, 2.56) 0.0001 0.0012 
Order Coriobacteriales 1.46 (1.03, 2.06) 0.03 0.35 
Order Turicibacterales 1.48 (1.01, 2.17) 0.04 0.35 
Family Erysipelotrichaceae 1.89 (1.39, 2.56) 0.0001 0.002 
Family Mogibacteriaceae 1.52 (1.05, 2.19) 0.02 0.34 
Family Coriobacteriaceae 1.46 (1.03, 2.06) 0.03 0.34 
Family Peptostreptococcaceae 1.44 (1.02, 2.03) 0.04 0.34 
Family Turicibacteraceae 1.48 (1.01, 2.17) 0.04 0.34 
Genus Catenibacterium 1.91 (1.36, 2.69) 0.0002 0.01 
Genus Collinsella 1.61 (1.13, 2.30) 0.01 0.21 
Genus Turicibacter 1.48 (1.01, 2.17) 0.04 0.50 


































*Odds Ratio of the presence probability  of taxa comparing current smokers to never smokers adjusting 
for age, sex, BMI, education, and betel quid use using logistic regression based on the dichotomous 
variable for presence/absence of taxa with a prevalence of >10% and <90%. A total of 142 bacterial taxa 
were tested.  Only the ones with nominal significance were listed. 
†P values were corrected for multiple testing using the Benjamini-Hochberg procedure to control the 













Class Alphaproteobacteria 4.85 (1.53, 15.39) 0.01 0.04 
Order GMD14H09 0.30 (0.11, 0.82) 0.02 0.19 
Family Christensenellaceae 3.62 (1.00, 13.09) 0.0499 0.63 
Genus Slackia 2.89 (1.12,  7.41) 0.03 0.27 






















Table 5. Odds ratio of mean relative abundances or presence/absence of bacterial taxa associated with 
one increase in packs smoked.  
 
Taxonomy 
Odds Ratio*  
(95% CI) 
P-value 
Abundance association test†   
Class Erysipelotrichi 1.88 (1.22, 2.89) 0.004 
Order Erysipelotrichales 1.88 (1.22, 2.89) 0.004 
Family Erysipelotrichaceae 1.88 (1.22, 2.89) 0.004 
Family Peptostreptococcaceae 1.67 (1.02, 2.69) 0.04 
Genus Slackia 2.75 (1.57, 4.76) 0.0004 
Genus Catenibacterium 1.90 (1.17, 3.03) 0.01 
Genus Collinsella 1.73 (1.05, 2.89) 0.03 
Presence/Absence association test#   
Genus Slackia 28.5 (3.9, 208.51) 0.001 
Genus Mitsuokella 20.7 (1.03, 411.58) 0.048 
 
*Odds Ratio of the mean relative abundance of taxa (abundance association test) or the mean presence 
probability of taxa (presence/absence association test) comparing smokers to never smokers adjusting 
for age, sex, BMI, education, and betel quid use. 
†Beta regression with logit transformation based on the continuous variable of relative abundance of 
taxa, replacing zeros with 10-6. 
#Logistic regression based on the dichotomous variable for presence/absence of taxa with a prevalence 
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